Carl Nathan, MD is R.A. Rees Pritchett Professor and chairman of the Department of Microbiology and Immunology at Weill Cornell Medicine. A graduate of Harvard College and Harvard Medical School, he trained in internal medicine and oncology at Massachusetts General Hospital, NCI and Yale before joining the faculty of Rockefeller University from 1977-1986. At Cornell since 1986, he has served as founding director of the Tri-Institutional MD-PhD Program, acting dean, and member of the Board of Directors of the Tri-Institutional Therapeutics Discovery Institute. He serves as co-chair of the editorial board of the Journal of Experimental Medicine and on the editorial boards of the Proceedings of the National Academy of Sciences and Science Translational Medicine. His research deals with the immunological and biochemical basis of host defense and involves new collaborative models between academia and industry to help invigorate antibiotic research and development. A member of the National Academy of Sciences, the National Academy of Medicine and the American Academy of Arts and Sciences, Nathan was awarded the Robert Koch Prize in 2009 and the Anthony Cerami Award in Translational Medicine in 2013.